Rani Therapeutics Holdings Inc (RANI)

May 29, 2025

Rani Therapeutics announces annual meeting results - Investing.com

May 29, 2025

May 29, 2025

Rani Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

May 29, 2025

May 25, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $9.40 Consensus PT from Brokerages - Defense World

May 25, 2025

May 23, 2025

What is Zacks Small Cap’s Estimate for RANI Q3 Earnings? - Defense World

May 23, 2025

May 22, 2025

Q2 Earnings Estimate for RANI Issued By Zacks Small Cap - Defense World

May 22, 2025

May 21, 2025

Rani Therapeutics (NASDAQ:RANI) Stock Price Up 7% – Here’s What Happened - Defense World

May 21, 2025

May 20, 2025

Rani Therapeutics Secures $4.3M via Series D Warrant - TipRanks

May 20, 2025

May 20, 2025

Rani Therapeutics strikes deal to issue new warrants - Investing.com

May 20, 2025

May 20, 2025

Rani Therapeutics strikes deal to issue new warrants By Investing.com - Investing.com UK

May 20, 2025

May 20, 2025

Rani Therapeutics Announces Research Agreement with Chugai - GlobeNewswire

May 20, 2025

May 19, 2025

Rani Therapeutics explores oral delivery of Chugai’s drugs - Investing.com Australia

May 19, 2025

May 19, 2025

RANI: 1Q:25 Financial Results - MSN

May 19, 2025

May 19, 2025

Rani Therapeutics (RANI) Partners with Chugai for Innovative Research | RANI Stock News - GuruFocus

May 19, 2025

May 19, 2025

Rani Therapeutics explores oral delivery of Chugai’s drugs By Investing.com - Investing.com India

May 19, 2025

May 19, 2025

Rani Therapeutics Enters Research Agreement with Chugai Pharmaceutical to Explore Oral Delivery Technology for Antibody Development - Nasdaq

May 19, 2025

May 19, 2025

Breakthrough: Rani's Oral Biologics Platform Matches Injectable Drugs in Chugai Partnership Study - Stock Titan

May 19, 2025

May 18, 2025

Oppenheimer Has Lowered Expectations for Rani Therapeutics (NASDAQ:RANI) Stock Price - Defense World

May 18, 2025

May 16, 2025

RANI Stock Update: Analyst Maintains Rating, Lowers Price Target | RANI Stock News - GuruFocus

May 16, 2025

May 16, 2025

Oppenheimer cuts Rani Therapeutics target to $4, keeps Outperform - Investing.com Australia

May 16, 2025

May 16, 2025

Oppenheimer cuts Rani Therapeutics target to $4, keeps Outperform By Investing.com - Investing.com Nigeria

May 16, 2025

May 16, 2025

Oppenheimer Adjusts Rani Therapeutics Price Target to $4 From $14, Maintains Outperform Rating - marketscreener.com

May 16, 2025

May 16, 2025

Oppenheimer Adjusts Rani Therapeutics (RANI) Price Target | RANI Stock News - GuruFocus

May 16, 2025

May 15, 2025

Rani Therapeutics Highlights Promising Preclinical Data - TipRanks

May 15, 2025

May 13, 2025

Rani Therapeutics Q1 2025 Earnings: EPS Misses at -$0.22, Revenue Surpasses Estimates at $0.2 Million - GuruFocus

May 13, 2025

May 13, 2025

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update - GlobeNewswire

May 13, 2025

May 13, 2025

Rani Therapeutics Q1 Net Income USD -12.738 Million - marketscreener.com

May 13, 2025

May 13, 2025

Rani Therapeutics Holdings, Inc. SEC 10-Q Report - TradingView

May 13, 2025

May 13, 2025

Rani Therapeutics Achieves Major Milestone: Oral Obesity Drug Shows Equal Success to Injections in Latest Data - Stock Titan

May 13, 2025

May 08, 2025

Ratio Analysis: Unpacking Rani Therapeutics Holdings Inc (RANI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 08, 2025

May 07, 2025

Rani Therapeutics faces Nasdaq delisting over market value By Investing.com - Investing.com India

May 07, 2025

May 06, 2025

Rani Therapeutics faces Nasdaq delisting over market value - Investing.com

May 06, 2025

May 06, 2025

Rani Therapeutics Faces Nasdaq Compliance Challenge - TipRanks

May 06, 2025

May 05, 2025

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update - ADVFN

May 05, 2025

May 03, 2025

Rani Therapeutics (RANI) Expected to Announce Quarterly Earnings on Monday - Defense World

May 03, 2025

Apr 30, 2025

Rani Therapeutics Board Restructures After DeBuono’s Retirement - TipRanks

Apr 30, 2025

Apr 28, 2025

Ratio Examination: Rani Therapeutics Holdings Inc (RANI)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

Apr 28, 2025

Apr 28, 2025

Daily Progress: XPLR Infrastructure LP (XIFR) Drop -1.51, Closing at 8.46 - DWinneX

Apr 28, 2025

Apr 28, 2025

Market Recap: PowerFleet Inc (AIOT)’s Negative Momentum, Closing at 5.12 - DWinneX

Apr 28, 2025

Apr 28, 2025

Market Highlights: Clear Channel Outdoor Holdings Inc (CCO) Ends on a Low Note at 1.02 - DWinneX

Apr 28, 2025

Apr 28, 2025

Post-Trade Analysis: Baytex Energy Corp (BTE) Climbs 0.61, Closing at 1.65 - DWinneX

Apr 28, 2025

Apr 27, 2025

Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $12.33 - Defense World

Apr 27, 2025

Apr 16, 2025

SEC Form DEFA14A filed by Rani Therapeutics Holdings Inc. - Quantisnow

Apr 16, 2025

Apr 05, 2025

HC Wainwright Reaffirms “Buy” Rating for Rani Therapeutics (NASDAQ:RANI) - Defense World

Apr 05, 2025

Apr 04, 2025

What is Zacks Small Cap’s Forecast for RANI FY2025 Earnings? - Defense World

Apr 04, 2025

Apr 02, 2025

Rani Therapeutics stock hits 52-week low at $1.24 - Investing.com Australia

Apr 02, 2025

Apr 02, 2025

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $12.33 Consensus PT from Analysts - Defense World

Apr 02, 2025

Apr 01, 2025

Rani Therapeutics Earnings Call: Tech Gains Amid Financial Strains - TipRanks

Apr 01, 2025

Apr 01, 2025

BTIG maintains Buy on Rani Therapeutics stock, $14 target - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

RANI: 2024 Financial Results - Yahoo Finance

Apr 01, 2025

Apr 01, 2025

Stifel maintains Buy on Rani Therapeutics, $8 target By Investing.com - Investing.com South Africa

Apr 01, 2025